← Tra cứu cổ phiếu
14,000 P/E8,15 lần P/B0,51 lần
Báo cáo tài chính

VMD · CTCP Y Dược phẩm Vimedimex

Báo cáo tài chính gốc theo dòng/kỳ (KQKD · Cân đối · Lưu chuyển tiền tệ).
Item 2024 2023 2022 2021 2020
Net Revenue
1,249.9 3,544.0 7,073.5 12,318.8 18,162.2
Cost of Goods Sold
1,130.9 3,255.8 6,528.7 0.0 0.0
Gross Profit
118.9 288.2 544.8 1,068.7 1,396.3
Financial Expenses
10.3 4.8 23.6 -174.5 -188.1
Selling Expenses
85.7 207.1 444.4 -826.1 -1,117.8
General and Administrative Expenses
27.7 43.1 68.2 -90.1 -92.2
Operating Profit
2.6 46.6 46.5 26.5 41.3
Profit Before Tax
30.6 43.6 47.4 28.2 50.4
Net Income
23.6 31.2 35.2 19.1 37.1
Profit Attributable to Parent
23.2 28.2 34.8 19.8 37.1
Earnings per Share
1,449.00 1,737.00 2,255.00 -525.00 2,400.76
Giải mã BCTC

Điểm nhấn trong BCTC của CTCP Y Dược phẩm Vimedimex (VMD) mà bạn nên biết

Q1/2025 On a TTM 2025Q1 basis, VMD has not accelerated revenue, but profitability is improving more visibly — margins have been expanding consistently over multiple periods.
Talk to an advisor about this stock